FEZAKINUMAB

UNII:	0S77U25XZ3
Formula:
Preferred Substance Name:	FEZAKINUMAB

1007106-86-6
FEZAKINUMAB [INN]
FEZAKINUMAB [USAN]
FEZAKINUMAB [WHO-DD]
ILV-094
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 22) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL .LAMBDA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 22) (HUMAN MONOCLONAL HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL .LAMBDA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN/MACACA IRUS/RATTUS/MUS MUSCULUS INTERLEUKIN 22) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL. .LAMBDA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN/MACACA IRUS/RATTUS/MUS MUSCULUS INTERLEUKIN 22) (HUMAN MONOCLONAL HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL. .LAMBDA.-CHAIN, DIMER

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

FEZAKINUMAB

Synonyms and Mappings

Resources